Page last updated: 2024-08-23

idarubicin and Pregnancy

idarubicin has been researched along with Pregnancy in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (10.00)18.2507
2000's8 (40.00)29.6817
2010's8 (40.00)24.3611
2020's2 (10.00)2.80

Authors

AuthorsStudies
Abe, Y; Ishida, T; Kasai, Y; Kasuya, Y; Kikuchi, T; Nomura, M; Norihama, Y; Oda, Y; Ogura, M; Sato, K; Takei, T; Tsukada, N1
Chan, SY; Dang, CC; Guan, YK; Lau, NS1
Emoto, I; Kanbayashi, S; Kim, T; Maruyama, S; Moriuchi, K; Ri, Y; Sato, Y; Taga, A1
Arnold, AJ; Gilmour, GS; Koch, MW1
Cavenagh, J; Ingram, W; Quinn, J; Smith, D; Stevens, J; Yong, K1
Casale, MF; de Lisa, E; Díaz-Mediavilla, J; Fernández, I; Fernández, P; González, JD; González-Campos, J; Herrera, P; Jiménez, S; Montesinos, P; Olave, T; Pellicer, A; Perales, A; Rojas, R; Salamero, O; Sanz, MA; Sayas, MJ1
Choi, JR; Han, JH; Kim, JK; Kim, JS; Kim, SJ; Lee, EY; Lee, HJ; Lee, KA; Lee, ST; Park, TS; Seok, YM; Song, J1
Driul, L; Fachechi, G; Ganzitti, L; Marchesoni, D1
Akiyama, N; Ayabe, T; Kawasugi, K; Nishi, R; Oka, Y; Shirafuji, N; Shirasaki, R; Shirota, M; Taguchi, A; Tashiro, H; Umezawa, K1
Aoki, A; Miyazono, T; Saito, S; Sugiyama, T; Yoneda, N; Yoneda, S1
Asea, A; Boos, J; Borkhardt, A; Dantonello, T; Hoehn, T; Klee, D; Koscielniak, E; Krefeld, B; Siepermann, M; Wessalowski, R1
Austin, N; Bayston, K; Carradice, D; Ganly, PS1
Consoli, U; Figuera, A; Giustolisi, R; Guido, G; Indelicato, F; Leotta, S; Meli, CR; Milone, G; Moschetti, G; Murgano, P; Pinto, V; Poidomani, M; Tornello, A1
Akercan, F; Cagirgan, S; Donmez, A; Mgoyi, L; Ozkinay, E; Vural, F; Yucebilgin, MS1
Gentilini, O; Goldhirsch, A; Martinelli, G; Peccatori, F1
Koyama, M; Matsuo, K; Murata, Y; Shimoya, K; Ueda, S; Wada, K1
Huerta, F; Reynoso, EE1
Claahsen, HL; Mattijssen, V; Semmekrot, BA; van Dongen, PW1
Achtari, C; Hohlfeld, P1
Alimena, G; Breccia, M; Cimino, G; De Carolis, S; Lo Coco, F; Mandelli, F1

Reviews

4 review(s) available for idarubicin and Pregnancy

ArticleYear
[Acute myelogenous leukemia developed at the 26th week of gestation].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2011, Volume: 52, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cesarean Section; Cytarabine; Female; Humans; Idarubicin; Infant, Low Birth Weight; Infant, Newborn; Leukemia, Myeloid, Acute; Male; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Outcome; Pregnancy Trimester, Second; Remission Induction

2011
Acute promyelocytic leukemia during pregnancy: report of 3 cases.
    International journal of hematology, 2004, Volume: 79, Issue:1

    Topics: Abnormalities, Drug-Induced; Abortion, Therapeutic; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Case Management; Cesarean Section; Fatal Outcome; Female; Gestational Age; Humans; Idarubicin; Infant, Newborn; Leukemia, Promyelocytic, Acute; Male; Pregnancy; Pregnancy Complications, Neoplastic; Remission Induction; Risk; Safety; Tretinoin

2004
Acute myeloblastic leukemia in pregnancy: a case report and review of the literature.
    European journal of gynaecological oncology, 2004, Volume: 25, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Diagnosis, Differential; Drug Administration Schedule; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Trimester, Third

2004
AIDA treatment for high-risk acute promyelocytic leukemia in a pregnant woman at 21 weeks of gestation.
    Haematologica, 2002, Volume: 87, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cesarean Section; Cytarabine; Disseminated Intravascular Coagulation; Female; Gestational Age; Humans; Idarubicin; Infant, Newborn; Leukemia, Promyelocytic, Acute; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Complications, Neoplastic; Remission Induction; Risk; Tretinoin

2002

Other Studies

16 other study(ies) available for idarubicin and Pregnancy

ArticleYear
[Acute myeloid leukemia with t (8;21) translocation diagnosed at 21 weeks of gestation resulting in full-term delivery without chemotherapy].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2023, Volume: 64, Issue:8

    Topics: Adult; Cesarean Section; Cytarabine; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Pregnancy; Translocation, Genetic

2023
Two successful deliveries of healthy children by a young woman diagnosed and treated during induction and relapsed therapy for acute promyelocytic leukemia.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2020, Volume: 26, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Cytarabine; Female; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Induction Chemotherapy; Leukemia, Promyelocytic, Acute; Pregnancy; Recurrence; Tretinoin; Young Adult

2020
Fetal death following idarubicin treatment for acute promyelocytic leukemia in pregnancy-A case report.
    European journal of obstetrics, gynecology, and reproductive biology, 2017, Volume: 218

    Topics: Adult; Antibiotics, Antineoplastic; Female; Fetal Death; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Pregnancy; Pregnancy Complications, Neoplastic

2017
Clinical Reasoning: A pregnant woman with chin numbness.
    Neurology, 2019, 02-26, Volume: 92, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow; Chin; Consolidation Chemotherapy; Cytarabine; Emergency Service, Hospital; Fatigue; Female; Hematopoietic Stem Cell Transplantation; Humans; Hypesthesia; Idarubicin; Induction Chemotherapy; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Meningeal Carcinomatosis; Paresthesia; Pregnancy; Pregnancy Complications, Neoplastic; Spinal Puncture; Sweating; Upper Extremity

2019
Myeloma presenting during pregnancy.
    Hematological oncology, 2014, Volume: 32, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Cesarean Section; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Contraindications; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Humans; Hypercalcemia; Idarubicin; Infant, Newborn; Lenalidomide; Male; Melphalan; Methylprednisolone; Multiple Myeloma; Myeloma Proteins; Osteolysis; Plasmacytoma; Postpartum Period; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pyrazines; Remission Induction; Spinal Cord Compression; Thalidomide; Thoracic Vertebrae; Transplantation, Autologous

2014
Maternal and fetal outcomes in pregnant women with acute promyelocytic leukemia.
    Annals of hematology, 2015, Volume: 94, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Databases, Factual; Female; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Remission Induction; Tretinoin; Young Adult

2015
Acute promyelocytic leukemia in early pregnancy with translocation t(15;17) and variant PML/RARA fusion transcripts.
    Cancer genetics and cytogenetics, 2009, Jan-01, Volume: 188, Issue:1

    Topics: Adult; Antineoplastic Agents; Bone Marrow; Female; Humans; Idarubicin; In Situ Hybridization, Fluorescence; Karyotyping; Korea; Leukemia, Promyelocytic, Acute; Nuclear Proteins; Oncogene Proteins, Fusion; Pregnancy; Pregnancy Complications, Neoplastic; Promyelocytic Leukemia Protein; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Reverse Transcriptase Polymerase Chain Reaction; Transcription Factors; Translocation, Genetic; Tretinoin; Tumor Suppressor Proteins

2009
Acute promyelocytic leukemia during pregnancy.
    Fertility and sterility, 2010, Volume: 94, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Female; Fetal Monitoring; Humans; Idarubicin; Infant, Newborn; Interdisciplinary Communication; Leukemia, Promyelocytic, Acute; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Trimester, Second; Tretinoin

2010
Massive postpartum hemorrhage after chemotherapy in a patient with acute promyelocytic leukemia.
    The journal of obstetrics and gynaecology research, 2011, Volume: 37, Issue:11

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Humans; Idarubicin; Induction Chemotherapy; Leukemia, Promyelocytic, Acute; Postpartum Hemorrhage; Pregnancy; Pregnancy Complications, Neoplastic; Tretinoin

2011
Oral low-dose chemotherapy: successful treatment of an alveolar rhabdomyosarcoma during pregnancy.
    Pediatric blood & cancer, 2012, Volume: 58, Issue:1

    Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Idarubicin; Pregnancy; Pregnancy Complications, Neoplastic; Prognosis; Rhabdomyosarcoma, Alveolar

2012
Successful treatment of acute promyelocytic leukaemia during pregnancy.
    Clinical and laboratory haematology, 2002, Volume: 24, Issue:5

    Topics: Adolescent; Anticonvulsants; Antineoplastic Combined Chemotherapy Protocols; Cerebral Hemorrhage; Cesarean Section; Dexamethasone; Diuretics; Epilepsy, Tonic-Clonic; Female; Fetal Growth Retardation; Humans; Idarubicin; Infant, Newborn; Leukemia, Promyelocytic, Acute; Lung; Neutropenia; Nutrition Disorders; Oxygen; Parenteral Nutrition, Total; Pregnancy; Pregnancy Complications; Pregnancy Complications, Neoplastic; Remission Induction; Respiration Disorders; Tranexamic Acid; Tretinoin

2002
Chemotherapy during pregnancy: what is really safe?
    The Lancet. Oncology, 2004, Volume: 5, Issue:7

    Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Doxorubicin; Epirubicin; Female; Fetal Diseases; Humans; Idarubicin; Maternal Exposure; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Treatment Outcome

2004
Idarubicin administered during pregnancy: its effects on the fetus.
    Gynecologic and obstetric investigation, 2004, Volume: 58, Issue:4

    Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cesarean Section; Drug Therapy, Combination; Female; Fetus; Gestational Age; Heart Rate, Fetal; Humans; Idarubicin; Leukemia, Myeloid, Acute; Placenta; Pregnancy; Pregnancy Complications, Neoplastic; Shock, Septic; Treatment Outcome

2004
Acute leukemia and pregnancy--fatal fetal outcome after exposure to idarubicin during the second trimester.
    Acta oncologica (Stockholm, Sweden), 1994, Volume: 33, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Fetal Death; Humans; Idarubicin; Leukemia, Erythroblastic, Acute; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Trimester, Second; Remission Induction

1994
Successful fetal outcome after exposure to idarubicin and cytosine-arabinoside during the second trimester of pregnancy--a case report.
    American journal of perinatology, 1998, Volume: 15, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Fetal Growth Retardation; Humans; Idarubicin; Infant, Newborn; Infant, Premature; Leukemia, Monocytic, Acute; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Prenatal Exposure Delayed Effects

1998
Cardiotoxic transplacental effect of idarubicin administered during the second trimester of pregnancy.
    American journal of obstetrics and gynecology, 2000, Volume: 183, Issue:2

    Topics: Adult; Antibiotics, Antineoplastic; Female; Heart; Humans; Idarubicin; Leukemia-Lymphoma, Adult T-Cell; Placenta; Pregnancy; Pregnancy Trimester, Second

2000